Cadian Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-31,956
| Closed | -$1.62M | – | 49 |
|
|
2016
Q3 | $1.62M | Sell |
31,956
-272,926
| -90% | -$13.8M | 0.09% | 47 |
|
|
2016
Q2 | $13.9M | Buy |
304,882
+20,000
| +7% | +$909K | 0.76% | 30 |
|
|
2016
Q1 | $11.3M | Sell |
284,882
-214,990
| -43% | -$8.5M | 0.76% | 30 |
|
|
2015
Q4 | $28.3M | Buy |
499,872
+139,475
| +39% | +$7.89M | 1.02% | 27 |
|
|
2015
Q3 | $14.3M | Buy |
360,397
+260,000
| +259% | +$10.3M | 0.52% | 49 |
|
|
2015
Q2 | $4.8M | Buy |
+100,397
| New | +$4.8M | 0.14% | 62 |
|